Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04996017
Title Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) (AtezoMeso)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gruppo Oncologico Italiano di Ricerca Clinica
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.